MIS-A is a serious disease that “hits” multiple organs of the body and causes generalized inflammation in the body

Scientists at the Centers for Disease Control and Prevention (CDC) announced for the first time that a mysterious “multisystem inflammatory syndrome” associated with Covid-19, not only occurs in children, as was perceived a few months ago but also in adults.

As the CDC states in its weekly scientific bulletin, “Morbidity and Mortality Weekly Report“ Multisystem Inflammatory Syndrome in Adults (MIS-A) is as rare as it is in children. The CDC reports 27 cases of this syndrome in adults between the ages of 21 and 50 in the United States and Britain. By the age of 20, the syndrome is typically considered “Children” (MIS-C) that also includes adolescents and young adults.

MIS-A is a serious disease that “hits” multiple organs of the body and causes generalized inflammation in the body. In almost all cases of the syndrome, in both children and adults, patients have been found to be positive for SARS-CoV-2 coronavirus or have antibodies against it, suggesting a recent infection with the virus.

The first reports of such a syndrome in children appeared in the spring. Young patients experience fever, abdominal pain, vomiting, diarrhea, rashes, fatigue,  etc. To date, 935 MIS-C cases have been diagnosed in the United States alone, of which 19 are fatal.

In adults, the symptoms are similar, plus sometimes chest pain and rapid palpitations. Of the known adult cases studied by the CDC, ten patients needed to be hospitalized in the ICU, while two died.

The Findings “indicate that adult patients of all ages with current or previous SARS-CoV-2 infection can develop a hyperinflammatory syndrome resembling MIS-C,” according to CDC scientists.

The CDC clarifies that patients hospitalized with Covid-19 generally experience inflammation and damage to organs other than the lungs. However, in most cases, these effects are accompanied by severe respiratory problems. In contrast, in the case of MIS-A syndrome, patients may have from no to mild breathing problems.

Scientists stress the need for further research on MIS-C and MIS-A syndromes in order to better illuminate their causes and possible long-term effects.